Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-057450
Filing Date
2025-04-23
Accepted
2025-04-23 16:30:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A vtyx_-_2025_addl_materia.htm DEFA14A 29702
2 GRAPHIC img219011483_0.jpg GRAPHIC 1194039
3 GRAPHIC img219011483_1.jpg GRAPHIC 94129
  Complete submission text file 0000950170-25-057450.txt   1803236
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40928 | Film No.: 25861977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)